Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients

Table 3 Risk factors selected from multivariate analysis

Covariates	Hazard ratio (95%CI)	P value
Age	1.068 (1.062-1.075)	< 0.001
Female	0.412 (0.344-0.494)	< 0.001
HLA mismatch level	0.951 (0.905-0.999)	0.043
Race
White	1	-
Black	0.124 (0.059-0.261)	< 0.001
Hispanic	0.058 (0.033-0.102)	< 0.001
Other	0.229 (0.154-0.340)	< 0.001
Diagnosis
Dilated myopathy	1	-
Restrictive myopathy	1.869 (1.333-2.619)	< 0.001
Heart re-transplant	1.711 (1.231-2.378)	0.001
Coronary artery disease	1.144 (0.935-1.400)	0.192
Hypertrophic myopathy	1.596 (1.087-2.345)	0.017
Valvular heart disease	1.159 (0.842-1.596)	0.364
Congenital heart defect	1.106 (0.649-1.886)	0.710
Other	1.381 (0.9477-2.012)	0.093
Malignancy at listing
No	1	-
Yes	1.593 (1.315-1.930)	< 0.001
Unknown	0.982 (0.666-1.448)	0.926
Induction with OKT3	1.380 (1.095-1.739)	0.006
Induction with daclizumab	1.371 (1.173-1.603)	< 0.001

HLA: Human leukocyte antigen; CI: Confidence interval.